Immatics IMTX
NASDAQ IMTX
$9.56 +0.10 (+1.06%)
As of: Sep 4, 2026 · 3:59 PM EDT

Immatics (IMTX) EBIT (2019 - 2026)

Immatics (IMTX) posted EBIT of -$417891.6 for Q4 2025, up 99.3% sequentially from -$59.6 million in Q3 2025, and down 100.91% YoY from $46.0 million in Q4 2024.

Analysis

Immatics (IMTX) EBIT (2019 - 2026) Analysis & Trends

Immatics has reported EBIT for 7 years, with the latest figure at -$417891.6 in Q4 2025.

  • Quarterly EBIT fell 100.91% year-over-year to -$417891.6 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$172.0 million (down 2228.55% YoY) and the FY2025 annual result came in at -$205.6 million, down 392.04% from the prior year.
  • EBIT advanced to -$417891.6 in Q4 2025 per IMTX's latest filing, from -$59.6 million in the prior quarter.
  • Over five years, EBIT peaked at $94.9 million in Q1 2022 and troughed at -$59.6 million in Q3 2025.
  • A 5-year average of -$16.9 million and a median of -$20.6 million in 2023 frame the typical range for EBIT.
  • The sharpest annual moves came in 2022 and 2025: EBIT surged 427.26% in 2022, then tumbled 2086.97% in 2025.
  • Over 5 years, EBIT stood at -$19.6 million in 2021, then increased by 12.75% to -$17.1 million in 2022, then slipped by 18.97% to -$20.3 million in 2023, then jumped by 326.32% to $46.0 million in 2024, then plunged by 100.91% to -$417891.6 in 2025.
  • According to Business Quant data, EBIT over the past three periods registered -$417891.6, -$59.6 million, and -$55.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.29 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 493.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -815.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -505.13 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 325.05 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 231.44 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 133.12 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -1.55 Mn
10 Immatics 1.17 Bn 711.21 Mn - -78.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -78.12 Mn
Mar 31, 2026 -77.34 Mn
Dec 31, 2025 -45.26 Mn
Sep 30, 2025 -63.87 Mn
Jun 30, 2025 -60.14 Mn
Mar 31, 2025 -37.21 Mn
Dec 31, 2024 964,941.65
Sep 30, 2024 564,484.82
Jun 30, 2024 -28.61 Mn
Mar 31, 2024 -14.63 Mn
Dec 31, 2023 -29.82 Mn
Sep 30, 2023 -36.21 Mn
Jun 30, 2023 -15.59 Mn
Mar 31, 2023 -28.37 Mn
Dec 31, 2022 45,911.13
Sep 30, 2022 -22.11 Mn
Jun 30, 2022 -17.77 Mn
Mar 31, 2022 76.87 Mn
Dec 31, 2021 -18.37 Mn
Sep 30, 2021 -27.12 Mn